Spots Global Cancer Trial Database for central nervous system lymphoma
Every month we try and update this database with for central nervous system lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular) | NCT03859544 | Central Nervous... | Retrospective s... | 18 Years - | Hospices Civils de Lyon | |
| Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma | NCT00267865 | AIDS-Related-Pr... | Methotrexate Rituximab Leucovorin | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas | NCT04548648 | Central Nervous... | Acalabrutinib Isavuconazole | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma | NCT05260619 | Central Nervous... | lenalidomide | 19 Years - | Seoul National University Bundang Hospital | |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma | NCT01722305 | B-Cell Lymphoma... Central Nervous... Intraocular Lym... Primary Diffuse... Recurrent Adult... Retinal Lymphom... | Dexamethasone Laboratory Biom... Pharmacological... Pomalidomide | 18 Years - | Mayo Clinic | |
| Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) | NCT03964090 | Central Nervous... Secondary Centr... | TEDD-R TEDDI-R Ibrutinib Cytarabine Isavuconazole Methotrexate | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular) | NCT03859544 | Central Nervous... | Retrospective s... | 18 Years - | Hospices Civils de Lyon | |
| Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL) | NCT02779101 | Primary Central... | pembrolizumab | 18 Years - | Medical University of Vienna | |
| Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia | NCT02952508 | Waldenstrom Mac... Multiple Myelom... Chronic Lymphoc... Small Lymphocyt... Lymphoplasmacyt... Marginal Zone L... Mantle Cell Lym... Diffuse Large B... Central Nervous... | Iopofosine I 13... Iopofosine I 13... Iopofosine I 13... | 18 Years - | Cellectar Biosciences, Inc. | |
| Study of Tissue Samples From Patients With Glioma or Other Brain Tumors | NCT00967200 | Central Nervous... | laboratory biom... pharmacogenomic... | 18 Years - 120 Years | University Hospital, Montpellier | |
| Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | NCT00293475 | Central Nervous... | Carboplatin Mannitol Methotrexate Quality-of-Life... Rituximab Sodium Thiosulf... | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) | NCT00916630 | Central Nervous... | pemetrexed | 18 Years - | Massachusetts General Hospital | |
| Secondary Central Nervous System Lymphoma Registry - Charité | NCT05114330 | Central Nervous... Non-Hodgkin Lym... | - | Charite University, Berlin, Germany | ||
| Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | NCT00293475 | Central Nervous... | Carboplatin Mannitol Methotrexate Quality-of-Life... Rituximab Sodium Thiosulf... | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL | NCT05054426 | Diffuse Large B... Central Nervous... | Methotrexate | 18 Years - | Peking Union Medical College Hospital | |
| Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma | NCT05209620 | Central Nervous... | ICP-022 Pemetrexed | 18 Years - 75 Years | Henan Cancer Hospital | |
| Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia | NCT02952508 | Waldenstrom Mac... Multiple Myelom... Chronic Lymphoc... Small Lymphocyt... Lymphoplasmacyt... Marginal Zone L... Mantle Cell Lym... Diffuse Large B... Central Nervous... | Iopofosine I 13... Iopofosine I 13... Iopofosine I 13... | 18 Years - | Cellectar Biosciences, Inc. | |
| Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy | NCT03690895 | Central Nervous... AIDS Related Ly... | Retrospective s... | 18 Years - | Fondation Ophtalmologique Adolphe de Rothschild | |
| Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy | NCT03690895 | Central Nervous... AIDS Related Ly... | Retrospective s... | 18 Years - | Fondation Ophtalmologique Adolphe de Rothschild | |
| Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma | NCT04938297 | Central Nervous... | Rituximab, Lena... Lenalidomide, Z... Lenalidomide | 18 Years - | Henan Cancer Hospital | |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma | NCT01458730 | Central Nervous... | Immunochemother... | 18 Years - 75 Years | University of Aarhus | |
| Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma | NCT05260619 | Central Nervous... | lenalidomide | 19 Years - | Seoul National University Bundang Hospital | |
| Long-term Follow-up Study of Patients Receiving CAR-T Cells | NCT03375619 | Chronic Lymphoc... Lymphomas Non-H... Lymphoma, Small... Mantle Cell Lym... Central Nervous... Diffuse Large B... Follicular Lymp... Burkitt Lymphom... Multiple Myelom... | Long-Term Follo... | 18 Years - 80 Years | Medical College of Wisconsin | |
| Acalabrutinib in CNSL | NCT04906902 | Central Nervous... Refractory Cent... Recurrent Centr... | Acalabrutinib | 18 Years - | Dana-Farber Cancer Institute | |
| Cognitive Functioning and Quality of Life in CNS Lymphoma | NCT00581737 | Lymphoma Central Nervous... | - | Memorial Sloan Kettering Cancer Center | ||
| Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma | NCT01011920 | Central Nervous... | Methotrexate Ara-C Rituximab Thiotepa radiotherapy BCNU APBSCT | 18 Years - 65 Years | International Extranodal Lymphoma Study Group (IELSG) | |
| A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma | NCT00221325 | Central Nervous... Intraocular Lym... | Intraventricula... | 18 Years - | University of California, San Francisco | |
| Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies | NCT05011045 | Central Nervous... Hematopoietic a... Leukemia Lymphoma Plasma Cell Mye... Secondary Centr... | Magnetic Resona... Neurocognitive ... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes) for the Treatment of Primary Central Nervous System Lymphoma | NCT05625594 | Central Nervous... | Aspiration Biospecimen Col... Catheterization CD19CAR-CD28-CD... Computed Tomogr... Cyclophosphamid... Fludarabine Leukapheresis Lumbar Puncture Magnetic Resona... Positron Emissi... | 18 Years - | City of Hope Medical Center | |
| Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma | NCT01722305 | B-Cell Lymphoma... Central Nervous... Intraocular Lym... Primary Diffuse... Recurrent Adult... Retinal Lymphom... | Dexamethasone Laboratory Biom... Pharmacological... Pomalidomide | 18 Years - | Mayo Clinic | |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| Selinexor in Combination With MTX+Ritu to Treat R/R CNSL | NCT05698147 | Central Nervous... | Selinexor Rituximab Methotrexate | 18 Years - 75 Years | Huashan Hospital | |
| Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma | NCT06031194 | Central Nervous... Diffuse Large B... | Non-Interventio... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL | NCT05054426 | Diffuse Large B... Central Nervous... | Methotrexate | 18 Years - | Peking Union Medical College Hospital | |
| Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL) | NCT02779101 | Primary Central... | pembrolizumab | 18 Years - | Medical University of Vienna | |
| Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) | NCT03964090 | Central Nervous... Secondary Centr... | TEDD-R TEDDI-R Ibrutinib Cytarabine Isavuconazole Methotrexate | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma | NCT00221325 | Central Nervous... Intraocular Lym... | Intraventricula... | 18 Years - | University of California, San Francisco | |
| Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) | NCT00153530 | Central Nervous... | methotrexate radiotherapy | 18 Years - | Charite University, Berlin, Germany |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
